Literature DB >> 18344410

A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.

S Imamura1, J Kobayashi, K Nakajima, S Sakasegawa, A Nohara, T Noguchi, M A Kawashiri, A Inazu, S S Deeb, H Mabuchi, J D Brunzell.   

Abstract

The objective of this study was to establish a new lipoprotein lipase (LPL) and hepatic lipase (HL) activity assay method. Seventy normal volunteers were recruited. Lipase activities were assayed by measuring the increase in absorbance at 546 nm due to the quinoneine dye. Reaction mixture-1 (R-1) contained dioleoylglycerol solubilized with lauryldimethylaminobetaine, monoacylglycerol-specific lipase, glycerolkinase, glycerol-3-phosphate oxidase, peroxidase, ascorbic acid oxidase, and apolipoprotein C-II (apoC-II). R-2 contained Tris-HCl (pH 8.7) and 4-aminoantipyrine. Automated assay of lipase activities was performed with an automatic clinical analyzer. In the assay for HL + LPL activity, 160 microl R-1 was incubated at 37 degrees C with 2 microl of sample for 5 min, and 80 microl R-2 was added. HL activities were measured under the same conditions without apoC-II. HL and LPL activities were also measured by the conventional isotope method and for HL mass by ELISA. Lipase activity detected in a 1.6 M NaCl-eluted fraction from a heparin-Sepharose column was enhanced by adding purified apoC-II in a dose-dependent manner, whereas that eluted by 0.8 M NaCl was not. Postheparin plasma-LPL and HL activities measured in the present automated method had high correlations with those measured by conventional activity and mass methods. This automated assay method for LPL and HL activities is simple and reliable and can be applied to an automatic clinical analyzer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344410      PMCID: PMC2431103          DOI: 10.1194/jlr.M700528-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  23 in total

1.  Idiopathic hyperlipemia: metabolic studies in an affected family.

Authors:  R J HAVEL; R S GORDON
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

2.  In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity.

Authors:  A Zambon; S S Deeb; A Bensadoun; K E Foster; J D Brunzell
Journal:  J Lipid Res       Date:  2000-12       Impact factor: 5.922

3.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.

Authors:  A Zambon; J E Hokanson; B G Brown; J D Brunzell
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

4.  A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women.

Authors:  M C Carr; J E Hokanson; S S Deeb; J Q Purnell; E S Mitchell; J D Brunzell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

5.  Development and evaluation of a direct sandwich-enzyme-linked immunosorbent assay for the quantification of human hepatic triglyceride lipase mass in human plasma.

Authors:  M Nishimura; Y Ohkaru; H Ishii; N Sunahara; A Takagi; Y Ikeda
Journal:  J Immunol Methods       Date:  2000-02-21       Impact factor: 2.303

Review 6.  Lipoprotein lipase: genetics, lipid uptake, and regulation.

Authors:  Martin Merkel; Robert H Eckel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

7.  A novel method for measuring human hepatic lipase activity in postheparin plasma.

Authors:  S Imamura; J Kobayashi; S Sakasegawa; A Nohara; K Nakajima; M Kawashiri; A Inazu; M Yamagishi; J Koizumi; H Mabuchi
Journal:  J Lipid Res       Date:  2006-11-07       Impact factor: 5.922

8.  Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms.

Authors:  Molly C Carr; John D Brunzell; Samir S Deeb
Journal:  J Lipid Res       Date:  2003-12-01       Impact factor: 5.922

9.  Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.

Authors:  P Magill; S N Rao; N E Miller; A Nicoll; J Brunzell; J St Hilaire; B Lewis
Journal:  Eur J Clin Invest       Date:  1982-04       Impact factor: 4.686

10.  Insulin and adipose tissue lipoprotein lipase activity in humans.

Authors:  J D Brunzell; R S Schwartz; R H Eckel; A P Goldberg
Journal:  Int J Obes       Date:  1981
View more
  10 in total

1.  GPIHBP1 autoantibody syndrome during interferon β1a treatment.

Authors:  Jun Eguchi; Kazuya Miyashita; Isamu Fukamachi; Katsuyuki Nakajima; Masami Murakami; Yuko Kawahara; Toru Yamashita; Yasuyuki Ohta; Koji Abe; Atsuko Nakatsuka; Mai Mino; Satoru Takase; Hiroaki Okazaki; Robert A Hegele; Michael Ploug; Xuchen Hu; Jun Wada; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2018-10-24       Impact factor: 4.766

2.  Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.

Authors:  Debapriya Basu; Jahan Manjur; Weijun Jin
Journal:  J Lipid Res       Date:  2011-01-26       Impact factor: 5.922

3.  A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase.

Authors:  Kazuya Miyashita; Katsuyuki Nakajima; Isamu Fukamachi; Yuji Muraba; Takafumi Koga; Yohnosuke Shimomura; Tetsuyo Machida; Masami Murakami; Junji Kobayashi
Journal:  J Lipid Res       Date:  2017-06-20       Impact factor: 5.922

Review 4.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

5.  Myocardial glucose and lactate metabolism during rest and atrial pacing in humans.

Authors:  Bryan C Bergman; Tatiana Tsvetkova; Brian Lowes; Eugene E Wolfel
Journal:  J Physiol       Date:  2009-03-16       Impact factor: 5.182

6.  Myocardial FFA metabolism during rest and atrial pacing in humans.

Authors:  Bryan C Bergman; Tatiana Tsvetkova; Brian Lowes; Eugene E Wolfel
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-09       Impact factor: 4.310

7.  Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.

Authors:  Mathilde Di Filippo; Christophe Marçais; Sybil Charrière; Oriane Marmontel; Martine Broyer; Mireille Delay; Micheline Merlin; Axel Nollace; René Valéro; Michel Lagarde; Valérie Pruneta-Deloche; Philippe Moulin; Agnès Sassolas
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

8.  Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model.

Authors:  Md Saddam Hussain; Nusrat Jahan; Md Mamun Or Rashid; Mohammad Salim Hossain; Umay Chen; Naimur Rahman
Journal:  Heliyon       Date:  2019-05-17

9.  Comparative lipid and uric acid suppressing properties of four common herbs in high fat-induced obese mice with their total phenolic and flavonoid index.

Authors:  Tanoy Mazumder; Imran Parvez Mamun; Md Safayat Zaman; A K M Khairul Islam; Shahjala Chowdhury; Md Sharif Reza; Md Saddam Hussain
Journal:  Biochem Biophys Rep       Date:  2021-03-30

10.  Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays.

Authors:  Dean Oldham; Hong Wang; Juliet Mullen; Emma Lietzke; Kayla Sprenger; Philip Reigan; Robert H Eckel; Kimberley D Bruce
Journal:  Front Cardiovasc Med       Date:  2022-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.